World Bio Summit 2025

Notifications

Schedule	Program	Content
Dat 1	Opening Ceremony	Opening Remarks, Welcoming Addresses, and Keynote Speech
	Main Session 1	Focused Development of Leading Innovative Technologies That Will Shape the Future
	부ide Session	① [Health AI] Challenges and Opportunities for Global Governance of AI in the Health Sector ② [ADB] Asian Networks for Vaccines, Therapeutics, and Diagnostic Devices to Strengthen Future Pandemic Response ③ [IVI] International Funding Opportunities: Strengthening Global Vaccine Research, Production, and Pandemic Preparedness
	Special Session	Promoting Vaccination for a Safe and Healthy Future
Day 2	Main Session 2	Robust, Resilient, and Rapidly Responsive Supply Chains
	Main Session 3	Linked and Collaborative, Consistent Workforce Development
	Closing Session	Session Briefing & Closing Ceremony
	Side Session	④ [Unitaid-KDCA] Cooperation to Strengthen Global Health Security: Preparing for the Development and Improved Access to Monoclonal Antibody Therapeutics ② [RIGHT 재단] End-to-End International Health R&D Approaches for Equitable Access to Essential Health Technologies

Agenda	Program	Description
Day 1	Opening Ceremony	Opening Remarks, Congratulatory Address, and Keynote Speech
	Main Session 1	Focused Development of Game-Changing Innovative Technologies
	Satellite Session	① [Health AI] Challenges and Opportunities for Global Governance of Health AI ② [ADB] Asian Vaccine, Therapeutics, and Diagnostics Network for Future Pandemic Preparedness ③ [IVI] Global Funding Opportunities – Strengthening Vaccine Research, Production, and Pandemic Preparedness
	Special Session	Promoting Immunization for a Safe and Healthy Future
Day 2	Main Session 2	A Robust, Resilient, and Responsive Supply Chain
	Main Session 3	Cooperation and Collaboration for Consistent Human Resource Development
	Closing Session	Session Briefing and Closing Remarks
	Side Session	- [Unitaid-KDCA] Collaboration to Strengthen Global Health Security : Preparation for the Development and Improved Accessibility of Monoclonal Antibody Therapeutics - [RIGHT Foundation] An End-to-End Approach to International Health R&D for Equitable Access to Essential Health Technologies